Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06514001 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of AMDX-2011P in Participants With Alzheimer's Disease

StatusRecruiting
PhasePhase 2
Started2025-03-07
View on ClinicalTrials.gov ↗
The purpose of this study is to assess safety, tolerability, plasma pharmacokinetics and biologic activity of a single intravenous dose of AMDX-2011P in participants with Alzheimer's Disease (AD).

Amendment history 2 changes detected by DataLookout

2026-09-01
Primary completion pushed: 2026-09 → 2027-07
2026-09-01
Completion pushed: 2026-10 → 2027-08
Trial Details
NCT Number NCT06514001
Lead Sponsor Amydis Inc.
Conditions Alzheimer Disease
Enrollment 25 participants
Start Date 2025-03-07
Primary Completion 2027-07 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-08-31